Andrew Tenney

Andrew Tenney has extensive work experience in the pharmaceutical industry. Andrew is currently serving as the Director of Commercial Operations at Avadel Pharmaceuticals plc. Prior to this role, they worked at Ocular Therapeutix, Inc. as the Director of Commercial Operations, where they developed strategies, systems, and processes to support the launch and commercialization of Dextenza. Andrew also established a high-performing team to coordinate resources and achieve corporate objectives. Before that, Andrew worked at Sanofi Genzyme as the Director of Field Sales Operations, overseeing operational functions for multiple brands and ensuring the portfolio exceeded annual forecasts. Andrew also held various roles at Pfizer, including Sr. Brand Manager, National Operations Manager, and Therapeutic Account Specialist. Throughout their career, Andrew has demonstrated expertise in sales, marketing, operations, and team leadership.

Andrew Tenney attended Loyola University Maryland from 1996 to 2000. During this time, they earned a Bachelor of Arts degree in Marketing. Andrew also received a Bachelor of Business Administration (BBA) from the Loyola University Maryland Sellinger School of Business, with a focus on Marketing.